A phase I, dose-finding study of sunitinib in combination with irinotecan in patients with advanced solid tumours

被引：0

作者：

E Boven

C Massard

J P Armand

C Tillier

V Hartog

N M Brega

A M Countouriotis

A Ruiz-Garcia

J C Soria

机构：

[1] VU University Medical Center,Department of Medical Oncology

[2] Institut Gustave Roussy,Department of Medicine

[3] Pfizer Italia Srl,undefined

[4] Torre A,undefined

[5] Pfizer Oncology,undefined

[6] 10646 Science Center Drive,undefined

来源：

British Journal of Cancer | 2010年 / 103卷

关键词：

sunitinib; irinotecan; combination; advanced solid tumours; pharmacokinetics;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：993 / 1000

页数：7

共 50 条

[21] Phase I dose-finding study of weekly docetaxel followed by flavopiridol for patients with advanced solid tumors
Fornier, M. N.
Rathkopf, D.
Shah, M.
Patil, S.
O'Reilly, E.
Tse, A. N.
Hudis, C.
Lefkowitz, R.
Kelsen, D. P.
Schwartz, G. K.
CLINICAL CANCER RESEARCH, 2007, 13 (19) : 5841 - 5846
[22] A phase I dose-finding clinical pharmacokinetic study of an oral formulation of irinotecan (CPT-11) administered for 5 days every 3 weeks in patients with advanced solid tumours
Dumez, H.
Awada, A.
Piccart, M.
Assadourian, S.
Semiond, D.
Guetens, G.
de Boeck, G.
Maes, R. A. A.
de Bruijn, E. A.
van Oosterom, A.
ANNALS OF ONCOLOGY, 2006, 17 (07) : 1158 - 1165
[23] Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation study
Robert, Francisco
Sandler, Alan
Schiller, Joan H.
Liu, Glenn
Harper, Karen
Verkh, Lev
Huang, Xin
Ilagan, Jennifer
Tye, Lesley
Chao, Richard
Traynor, Anne M.
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (04) : 669 - 680
[24] Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation study
Francisco Robert
Alan Sandler
Joan H. Schiller
Glenn Liu
Karen Harper
Lev Verkh
Xin Huang
Jennifer Ilagan
Lesley Tye
Richard Chao
Anne M. Traynor
Cancer Chemotherapy and Pharmacology, 2010, 66 : 669 - 680
[25] Phase I dose-finding and pharmacokinetic study of a combination of elisidepsin (E) and erlotinib (T) in patients (pts) with advanced solid tumors.
Goel, Sanjay
Moran, Teresa
Coronado, Cinthya
Ramirez, Santiago Viteri
Chaudhary, Imran
Ghalib, Mohammad Haroon
Swami, Umang
Hou, Yijuan
Carcereny, Enric
Alcantara, Jose
Dios, Jorge Luis Iglesias
De Miguel, Bernardo
Buges, Cristina
Rosell, Rafael
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[26] Clofarabine administration weekly to adult patients with advanced solid tumors in a phase I dose-finding study.
Cunningham, CC
Nemunaitis, J
Senzer, N
Vukelja, S
Richards, D
Vukovic, V
Weitman, S
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 647S - 647S
[27] Phase I dose-finding and pharmacokinetic study of paclitaxel and carboplatin with oral valspodar in patients with advanced solid tumors
Patnaik, A
Warner, E
Michael, M
Egorin, MJ
Moore, MJ
Siu, LL
Fracasso, PM
Rivkin, S
Kerr, I
Litchman, M
Oza, AM
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (21) : 3677 - 3689
[28] A PHASE I AND DOSE-FINDING STUDY OF LENVATINIB (E7080) IN JAPANESE PATIENTS WITH ADVANCED SOLID TUMORS
Yamamoto, N.
Nokihara, H.
Yamada, Y.
Honda, K.
Wakui, H.
Sasaki, T.
Yusa, W.
Tamura, T.
ANNALS OF ONCOLOGY, 2013, 24
[29] Phase I dose-finding study of weekly single-agent patupilone in patients with advanced solid tumors
Rubin, EH
Rothermel, J
Tesfaye, F
Chen, TL
Hubert, M
Ho, YY
Hsu, CH
Oza, AM
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (36) : 9120 - 9129
[30] A dose-finding and pharmacodynamic study of bortezomib in combination with weekly paclitaxel in patients with advanced solid tumors
Bhuvaneswari Ramaswamy
Tanios Bekaii-Saab
Larry J. Schaaf
Gregory B. Lesinski
David M. Lucas
Donn C. Young
Amy S. Ruppert
John C. Byrd
Kristy Culler
Diedre Wilkins
John J. Wright
Michael R. Grever
Charles L. Shapiro
Cancer Chemotherapy and Pharmacology, 2010, 66 : 151 - 158

← 1 2 3 4 5 →